Crew Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,127
Closed -$931K 131
2025
Q1
$931K Buy
1,127
+75
+7% +$62.4K 0.76% 42
2024
Q4
$812K Buy
1,052
+699
+198% +$579K 0.67% 50
2024
Q3
$313K Sell
353
-7,744
-96% -$6.96M 0.25% 99
2024
Q2
$7.33M Sell
8,097
-82
-1% -$65.6K 5.87% 1
2024
Q1
$6.36M Sell
8,179
-959
-10% -$682K 5.16% 3
2023
Q4
$5.33M Sell
9,138
-83
-0.9% -$48.4K 5.42% 5
2023
Q3
$4.95M Sell
9,221
-295
-3% -$152K 5.33% 5
2023
Q2
$4.46M Sell
9,516
-1,001
-10% -$420K 5.08% 5
2023
Q1
$3.61M Sell
10,517
-17
-0.2% -$5.73K 5.19% 3
2022
Q4
$3.85M Sell
10,534
-8
-0.1% -$2.84K 5.53% 3
2022
Q3
$3.41M Hold
10,542
4.64% 3
2022
Q2
$3.42M Hold
10,542
4.3% 3
2022
Q1
$3.02M Sell
10,542
-600
-5% -$154K 2.91% 7
2021
Q4
$3.08M Buy
11,142
+50
+0.5% +$12.7K 2.6% 10
2021
Q3
$2.56M Hold
11,092
2.38% 14
2021
Q2
$2.55M Hold
11,092
2.38% 14
2021
Q1
$2.07M Buy
+11,092
New +$2.17M 2.07% 15

Other funds holding LLY

Crew Capital Management's LLY Position: Q2 2025 in Review

Crew Capital Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 1,127 shares — an estimated $931K sold.

Crew Capital Management first reported a position in LLY in Q1 2021 and held it in 17 quarters. The position peaked at $7.33M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Crew Capital Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Crew Capital Management sold 1,127 Eli Lilly shares in Q2 2025, an estimated $931K.
  • Crew Capital Management first reported a position in Eli Lilly in Q1 2021 and held it in 17 quarters.
  • Crew Capital Management's Eli Lilly position peaked at $7.33M in Q2 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Crew Capital Management's 13F filing for Q2 2025, filed 14 Jul 2025.